Chronic Lymphocytic Leukemia News and Research

RSS
Chronic Lymphocytic Leukemia (CLL) is the most common form of leukemia in adults. According to the American Cancer Society, approximately 8,000 patients will be diagnosed this year. More than 60,000 people in the U.S. currently have CLL. The disease arises in lymphocytes, a type of white blood cell that normally produces antibodies and serves important immune functions.
New prognostic tool could help improve clinical decision making for leukemia patients

New prognostic tool could help improve clinical decision making for leukemia patients

New prognostic tool helps leukemia patients plan for cancer treatment

New prognostic tool helps leukemia patients plan for cancer treatment

Single gene cluster loss promotes initiation and progression of multiple myeloma in mice

Single gene cluster loss promotes initiation and progression of multiple myeloma in mice

Universal 'One-Size-Fits-All' Cancer Treatment

Universal 'One-Size-Fits-All' Cancer Treatment

CD19 CAR NK cell therapy clinical trial shows encouraging results for hematologic cancers

CD19 CAR NK cell therapy clinical trial shows encouraging results for hematologic cancers

AMSBIO announces new Custom CAR-T development service

AMSBIO announces new Custom CAR-T development service

FDA gives clearance to IND application for Calibr's 'switchable' CAR-T cell therapy

FDA gives clearance to IND application for Calibr's 'switchable' CAR-T cell therapy

Researchers reveal mutation's role in blood cancers

Researchers reveal mutation's role in blood cancers

Study may help develop ibrutinib-based combination therapies for blood cancer

Study may help develop ibrutinib-based combination therapies for blood cancer

OGT launches high-quality NGS panel for research into Chronic Lymphocytic Leukemia

OGT launches high-quality NGS panel for research into Chronic Lymphocytic Leukemia

Risk of specific genetic translocation is higher in patients of African ancestry, shows study

Risk of specific genetic translocation is higher in patients of African ancestry, shows study

New strategies needed to manage ibrutinib-related toxicities in CLL patients, study suggests

New strategies needed to manage ibrutinib-related toxicities in CLL patients, study suggests

Thermo Fisher Scientific to accelerate genomic profiling process in hematology and oncology labs

Thermo Fisher Scientific to accelerate genomic profiling process in hematology and oncology labs

Ibrutinib-based therapy provides superior clinical outcomes in majority of CLL patients

Ibrutinib-based therapy provides superior clinical outcomes in majority of CLL patients

FDA approves Ohio State-developed drug to treat patients with CLL and SCL

FDA approves Ohio State-developed drug to treat patients with CLL and SCL

Cancer drug shows promise in treating metabolic syndrome

Cancer drug shows promise in treating metabolic syndrome

Rutgers researcher receives $600,000 grant to study chronic lymphocytic leukemia

Rutgers researcher receives $600,000 grant to study chronic lymphocytic leukemia

MD Anderson and Takeda announce agreement to develop off-the-shelf CAR NK-cell therapy platform

MD Anderson and Takeda announce agreement to develop off-the-shelf CAR NK-cell therapy platform

Scientists harness the power of immune system to test novel cancer treatment

Scientists harness the power of immune system to test novel cancer treatment

Novel cancer-driving mutation discovered in vast non-coding regions of the cancer genome

Novel cancer-driving mutation discovered in vast non-coding regions of the cancer genome